Mesa Laboratories MLAB
$127.93 −$5.48 (-4.11%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $127.93 0.00%
Open$131.62
Prev close$133.41
Day range$126.73 – $134.00
Volume76.0K
Market cap$719.03M
P/E (TTM)110.3
Dividend yield0.50%
Fundamentals
Latest reported quarter: Q2, ended Sep 2026
Revenue$62.34M+2.6% YoY
Operating profit$8.39M+77.6% YoY
Net profit$4.34M+75.3% YoY
Diluted EPS$0.75+66.7% YoY
Free cash flow$3.71M-48.0% YoY
Operating cash flow$4.10M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin64.8%
Operating margin10.4%
Net margin2.7%
Return on equity3.6%
Return on assets1.6%
Return on invested capital3.7%
Current ratio1.90
Liabilities / assets52.3%
Cash & investments$22.31M
Total debt$131.51M
Net cash (debt)-$109.19M
Free cash flow / sales19.7%
Where the revenue comes from
Quarter 2027/Q2
By business line
Income statement
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $62.34M | $60.14M | $249.13M | $63.72M | $65.13M |
| Total Operating Revenue | $62.34M | $60.14M | $249.13M | $63.72M | $65.13M |
| Cost of Revenue | $22.46M | $21.13M | $90.86M | $21.52M | $23.33M |
| Gross Profit | $39.88M | $39.01M | $158.27M | $42.21M | $41.80M |
| Operating Expense | $31.49M | $31.98M | $139.76M | $39.46M | $33.82M |
| Selling and Admin Expenses | $26.44M | $27.26M | $119.45M | $34.21M | $28.79M |
| -Selling & Marketing Expense | $9.83M | $9.87M | $40.79M | $10.08M | $9.99M |
| -General & Admin Expense | $16.61M | $17.38M | $78.66M | $24.13M | $18.81M |
| Research & Development | $5.05M | $4.73M | $20.31M | $5.25M | $5.03M |
| Operating Profit | $8.39M | $7.03M | $18.51M | $2.75M | $7.98M |
| Net Non-Operating Interest Income (Expense) | -$2.14M | -$2.36M | -$10.69M | -$2.60M | -$3.04M |
| Non-Operating Interest Expense | $2.14M | $2.36M | $10.69M | $2.60M | $3.04M |
| Other Income (Expense) | -$217,000.00 | -$315,000.00 | $4.20M | -$1.75M | -$343,000.00 |
| Other Non-Operating Income (Expenses) | -$217,000.00 | -$315,000.00 | $4.20M | -$1.75M | -$343,000.00 |
| Pretax Profit | $6.03M | $4.35M | $12.01M | -$1.59M | $4.60M |
| Tax | $1.69M | $1.52M | $5.30M | $2.54M | $966,000.00 |
| Net Profit | $4.34M | $2.83M | $6.71M | -$4.14M | $3.63M |
| Profit from Continuing Operations | $4.34M | $2.83M | $6.71M | -$4.14M | $3.63M |
| Net Income to Parent Company | $4.34M | $2.83M | $6.71M | -$4.14M | $3.63M |
| Net Income to Common Stockholders | $4.34M | $2.83M | $6.71M | -$4.14M | $3.63M |
| Basic EPS | $0.77 | $0.50 | $1.22 | -$0.75 | $0.66 |
| Diluted EPS | $0.75 | $0.49 | $1.21 | -$0.75 | $0.65 |
| Dividend Per Share | $0.16 | $0.16 | $0.64 | $0.16 | $0.16 |
| Special Income (Charges) | – | – | $0.00 | $0.00 | $0.00 |
| -Less:Impairment of Capital Assets | – | – | $0.00 | – | – |
Balance sheet
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Total Assets | $407.74M | $419.22M | $427.75M | $427.75M | $434.85M |
| Total Current Assets | $98.25M | $102.85M | $106.27M | $106.27M | $105.63M |
| Cash and Cash Equivalents & Short-Term Investments | $22.31M | $30.70M | $26.93M | $26.93M | $28.98M |
| -Cash and Cash Equivalents | $22.31M | $30.70M | $26.93M | $26.93M | $28.98M |
| Receivables | $39.38M | $34.41M | $44.10M | $44.10M | $40.23M |
| -Accounts Receivable | $39.38M | $34.41M | $44.10M | $44.10M | $40.23M |
| Prepaid Assets | $5.13M | $6.04M | $5.25M | $5.25M | $5.93M |
| Inventory | $26.55M | $27.23M | $26.37M | $26.37M | $26.56M |
| Other Current Assets | $4.88M | $4.48M | $3.62M | $3.62M | $3.93M |
| Total Non-Current Assets | $309.49M | $316.38M | $321.48M | $321.48M | $329.22M |
| Net PPE | $29.35M | $30.09M | $30.61M | $30.61M | $31.60M |
| -Gross PPE | $60.96M | $61.20M | $60.73M | $60.73M | $61.50M |
| -Accumulated Depreciation | -$31.61M | -$31.11M | -$30.12M | -$30.12M | -$29.90M |
| Goodwill and Other Intangible Assets | $258.75M | $264.44M | $270.21M | $270.21M | $278.95M |
| -Goodwill | $185.24M | $186.04M | $186.86M | $186.86M | $189.30M |
| -Other Intangible Assets | $73.51M | $78.40M | $83.35M | $83.35M | $89.65M |
| Non-Current Deferred Assets | $1.49M | $1.49M | $1.50M | $1.50M | $1.47M |
| Other Non-Current Assets | $19.91M | $20.36M | $19.16M | $19.16M | $17.20M |
| Total Liabilities | $213.14M | $230.46M | $241.50M | $241.50M | $248.16M |
| Total Current Liabilities | $51.58M | $57.32M | $61.90M | $61.90M | $54.40M |
| Payables | $27.50M | $32.28M | $35.63M | $35.63M | $28.35M |
| -Accounts Payable | $4.82M | $7.46M | $4.93M | $4.93M | $5.25M |
| -Total Tax Payable | $12.74M | $14.58M | $14.01M | $14.01M | $11.53M |
| -Other Payable | $9.93M | $10.24M | $16.69M | $16.69M | $11.58M |
| Current Accrued Expenses | $2.21M | $2.27M | $2.23M | $2.23M | $2.44M |
| Short-Term Debt and Capital Lease Obligation | $7.87M | $8.26M | $9.31M | $9.31M | $9.05M |
| -Current Debt | $5.63M | $5.63M | $5.63M | $5.63M | $5.16M |
| -Current Capital Lease Obligation | $2.24M | $2.63M | $3.69M | $3.69M | $3.89M |
| Current Deferred Liabilities | $14.01M | $14.52M | $14.72M | $14.72M | $14.56M |
| Total Non-Current Liabilities | $161.56M | $173.14M | $179.60M | $179.60M | $193.76M |
| Long Term Debt and Capital Lease Obligation | $125.88M | $137.24M | $145.86M | $145.86M | $171.93M |
| -Long Term Debt | $125.88M | $137.24M | $145.86M | $145.86M | $160.97M |
| Non-Current Deferred Liabilities | $19.92M | $20.05M | $20.09M | $20.09M | $21.83M |
| Other Non-Current Liabilities | $15.75M | $15.85M | $13.66M | $13.66M | – |
| Total Equity | $194.60M | $188.76M | $186.25M | $186.25M | $186.69M |
| Stockholders' Equity | $194.60M | $188.76M | $186.25M | $186.25M | $186.69M |
| Capital Stock | $380.13M | $376.75M | $375.35M | $375.35M | $368.56M |
| -Common Stock | $380.13M | $376.75M | $375.35M | $375.35M | $368.56M |
| Retained Earnings | -$180.36M | -$183.80M | -$185.75M | -$185.75M | -$180.73M |
| Gains/Losses Not Affecting Retained Earnings | -$5.17M | -$4.19M | -$3.36M | -$3.36M | -$1.14M |
| -Long Term Capital Lease Obligation | – | – | – | – | $10.96M |
Cash flow
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $4.10M | $14.74M | $42.83M | $13.96M | $18.75M |
| Net cash flow from continuing operations | $4.10M | $14.74M | $42.83M | $13.96M | $18.75M |
| Net Income from Continuing Operations | $4.34M | $2.83M | $6.71M | -$4.14M | $3.63M |
| Gain/Loss from Continuing Operations | $149,000.00 | $354,000.00 | – | – | $281,000.00 |
| Depreciation & Depletion & Amortization | $5.56M | $5.65M | $23.27M | $5.75M | $5.72M |
| Other Non-Cash Items | $738,000.00 | $623,000.00 | $1.26M | -$2.88M | $1.26M |
| Change in Working Capital | -$10.07M | $2.93M | -$4.99M | $3.93M | $4.48M |
| -Change in Receivables | -$5.10M | $9.78M | -$3.21M | -$4.13M | -$819,000.00 |
| -Change in Inventory | -$298,000.00 | -$1.53M | -$4.43M | -$974,000.00 | $596,000.00 |
| -Change in Prepaid Assets | $204,000.00 | -$2.28M | $608,000.00 | $2.15M | -$715,000.00 |
| -Change in Payables and Accrued Expense | -$4.38M | -$2.87M | $2.30M | $6.62M | $5.18M |
| -Change In Other Working Capital | -$498,000.00 | -$171,000.00 | -$255,000.00 | $259,000.00 | $244,000.00 |
| Net cash flow from investing | -$387,000.00 | -$559,000.00 | -$3.25M | -$417,000.00 | -$732,000.00 |
| Net Cash Flow from Continuing Investing Activities | -$387,000.00 | -$559,000.00 | -$3.25M | -$417,000.00 | -$732,000.00 |
| Net PPE Purchase and Sale | -$387,000.00 | -$559,000.00 | -$3.25M | -$417,000.00 | -$732,000.00 |
| Financing Cash Flow | -$12.31M | -$10.50M | -$41.85M | -$15.76M | -$9.79M |
| Net Cash Flow from Continuing Financing Activities | -$12.31M | -$10.50M | -$41.85M | -$15.76M | -$9.79M |
| Net Issuance Payments Of Debt | -$11.41M | -$8.66M | -$26.75M | -$14.69M | -$8.69M |
| Cash Dividends Paid | -$898,000.00 | -$884,000.00 | -$3.52M | -$884,000.00 | -$884,000.00 |
| Net Other Financing Charges | -$10,000.00 | -$958,000.00 | -$11.58M | -$188,000.00 | -$214,000.00 |
| Ending Cash Balance | $22.31M | $30.70M | $26.93M | $26.93M | $28.98M |
| Net Change in Cash | -$8.61M | $3.68M | -$2.27M | -$2.21M | $8.24M |
| Beginning Cash Balance | $30.70M | $26.93M | $27.32M | $28.98M | $20.42M |
| Effect of Exchange Rate Changes | $222,000.00 | $88,000.00 | $1.88M | $167,000.00 | $316,000.00 |
| Free Cash Flow | $3.71M | $14.18M | $39.58M | $13.55M | $18.02M |
| Deferred Tax | – | – | -$1.29M | – | – |
| Net Intangibles Purchase and Sale | – | – | $0.00 | – | – |
| Net Business Purchase and Sale | – | – | $0.00 | – | – |
| Proceeds from Stock Option Exercised | – | – | $0.00 | – | – |
No comments yet — be the first to weigh in on MLAB.
Sign in to join the discussion.